Infusion Devices: Technologies and Global Markets

Report Code: HLC071A

Publish Date: Feb 2010

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Global spending on infusion pumps were $6.4 billion in 2008 which increased to $7 billion in 2009. This is projected to reach $9.6 billion in 2014 at a compound annual growth rate (CAGR) of 6.5%
  • Spending alone in USA was nearly $3.3 billion in 2008 which increased to $3.6 billion in 2009. This is projected to reach $4.8 billion in 2014 at a compound annual growth rate (CAGR) of 5.8%
  • Spending in Europe was $1.9 billion in 2008, which increased slightly in 2009 to $2 billion. This market is projected to reach approx $2.8 billion in 2014, for a 5-year CAGR of 6.4%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
BCC’s goal in conducting this study was to determine the current status of the global market for infusion pumps and assess its growth potential over a 5-year period from 2009 to 2014. Of particular interest were changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls over the past 2 years.
In addition, BCC was interested in describing the transition to “smart pump” technology and giving an overview of the complex systems that complement and compete with infusion pumps as mode of treatment. 
The key objective was to present a comprehensive analysis of the current market for infusion pumps and its future growth prospects in providing safe and effective delivery of medications, nutrients, and analgesics.
REASONS FOR DOING THE STUDY
Almost every aspect of the infusion pump sector is undergoing dramatic change at this time. In response to numerous product recalls, manufacturers have introduced new smart pump technology to reduce Adverse Drug Events (ADEs) and other serious problems associated with previous administrative methods. 
Competition from other drug delivery systems, chiefly transdermal and inhaled medicines, may put boundaries on growth for infusion pumps. Demand is growing for continuous administration of medicines and analgesics due to demographic changes in the world’s population and the increasing incidence of diabetes. Ancillary devices such as meters and monitors are becoming a significant force in the market, and design changes have produced new pumps that are smaller, less obtrusive, and have a sense of style, rendering them much more acceptable as ambulatory infusion pumps.
BCC is interested in charting the interplay between these various factors and how they will interact with other changes occurring in the broader landscape of healthcare delivery. 
SCOPE OF REPORT
 
This report covers infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics. BCC analyzes current conditions in the global market and examines the current market condition and variable factors to forecast the future growth of the market. Medical, scientific, technological, social, and economic issues associated with this market are examined. An educated estimate and forecast of growth from 2009 to 2014 are presented by examining the current market and variable factors of each category of diagnostic or therapeutic product. 
INTENDED AUDIENCE
 
BCC has compiled a study of the global market for infusion pumps, with an examination of how they interact with other selected drug delivery systems.
We examined current Food and Drug Administration (FDA)-approved medical devices by each category, industry pipelines, and technology innovation through patent protection in the U.S. Patent and Trademark Office (USPTO), the European Patent Office (EPO), and the World Intellectual Property Organization (WIPO), and market competition from transdermal drug-delivery systems and inhaled medications.
Forecasts of the infusion pump market are undertaken by examination of medical and scientific issues, the economic environment, technology innovation, industry pipeline development, market competition, and market growth potential from 2009 to 2014. Market leaders and smaller innovative companies are also introduced.
This study will be of interest to the global pharmaceutical industry, drug and medical device manufacturers, drug and medical device distributors, healthcare maintenance organizations (HMOs) and hospitals, insurance underwriters, government agency regulators, government policy makers, institutional and private investors, and various patient educational communities. 
INFORMATION SOURCES
 
BCC surveyed approximately 45 companies to obtain data for this study. Included were manufacturers of infusion pumps, transdermal drug delivery systems, inhaled medications, glucose monitoring devices, medical device distributors, pharmaceutical manufacturers, and manufacturers of needleless injectors. BCC also spoke with government agency regulators, industry personnel, and medical science personnel. In addition, data was compiled from current financial, legal, trade information, and government sources.
ANALYST CREDENTIALS
Thomas Fuller has been a market research analyst for 15 years and has published numerous reports on technology products and market issues. Fuller has broad experience in covering regulatory and consumer issues, and currently advises companies on business strategy in the healthcare sector.
BCC ONLINE SERVICES 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER 

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Infusion Devices: Technologies and Global Markets195Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY4Free
Chapter- 3: OVERVIEW17Free
Chapter- 4: MAJOR COMPANIES AND MARKET SHARE8Free
Chapter- 5: MARKETS BY PRODUCT16Free
Chapter- 6: TYPES OF APPLICATIONS15Free
Chapter- 7: CONDITIONS7Free
Chapter- 8: COMPETING AND COMPLEMENTARY TECHNOLOGIES21Free
Chapter- 9: GOVERNMENT REGULATIONS16Free
Chapter- 10: CLINICAL GUIDELINES BY PROFESSIONAL GROUPS3Free
Chapter- 11: PATIENT SAFETY3Free
Chapter- 12: INDUSTRY STRUCTURE12Free
Chapter- 13: INTERNATIONAL ASPECTS8Free
Chapter- 14: TRENDS IN PRICE AND PRICE/PERFORMANCE11Free
Chapter- 15: TECHNOLOGY, INCLUDING PATENT EVALUATION9Free
Chapter- 16: C. CRAMER & CO. GMBH37Free
Chapter- 17: APPENDIX5Free

Related Reports

Recent Reports

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Plastics for Healthcare Packaging

Published - May 2024 | Publisher - BCC Publishing | Code - PLS007G

The global market value of plastics for healthcare packaging is expected to grow from $32.1 billion in 2023 and should reach $46.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Infusion Devices: Technologies and Global Markets
Customize Report